Impact of Fibrotic Metabolic Dysfunction-Associated Steatohepatitis as a New Indication on Semaglutide Eligibility in the US Adult Population.
Saved in:
| Title: | Impact of Fibrotic Metabolic Dysfunction-Associated Steatohepatitis as a New Indication on Semaglutide Eligibility in the US Adult Population. |
|---|---|
| Authors: | van Kleef LA; Department of Gastroenterology and Hepatology, Erasmus MC, University Medical Center, Rotterdam, The Netherlands., Michel M; Department of Internal Medicine II, Saarland University Medical Center, Homburg, Germany.; Medical Faculty, Saarland University, Saarbrücken, Germany., Savas M; Department of Internal Medicine, Division of Endocrinology, Erasmus MC, University Medical Center, Rotterdam, The Netherlands.; Obesity Center CGG, Erasmus MC, University Medical Center, Rotterdam, The Netherlands., Pustjens J; Department of Gastroenterology and Hepatology, Erasmus MC, University Medical Center, Rotterdam, The Netherlands., Theel W; Department of Gastroenterology and Hepatology, Erasmus MC, University Medical Center, Rotterdam, The Netherlands., van Rossum EFC; Department of Internal Medicine, Division of Endocrinology, Erasmus MC, University Medical Center, Rotterdam, The Netherlands.; Obesity Center CGG, Erasmus MC, University Medical Center, Rotterdam, The Netherlands., Paik JM; The Global NASH Council, Washington, District of Columbia.; Beatty Liver and Obesity Research Program, Inova Health System, Falls Church, Virginia., Younossi ZM; The Global NASH Council, Washington, District of Columbia.; Beatty Liver and Obesity Research Program, Inova Health System, Falls Church, Virginia., Janssen HLA; Department of Gastroenterology and Hepatology, Erasmus MC, University Medical Center, Rotterdam, The Netherlands.; Toronto Centre for Liver Disease, Toronto General Hospital, University Health Network, Toronto, Canada., Labenz C; Department of Gastroenterology and Hepatology, University Medical Center Mainz, Mainz, Germany., Schattenberg JM; Department of Internal Medicine II, Saarland University Medical Center, Homburg, Germany.; Medical Faculty, Saarland University, Saarbrücken, Germany., Brouwer WP; Department of Gastroenterology and Hepatology, Erasmus MC, University Medical Center, Rotterdam, The Netherlands. |
| Source: | Gastro hep advances [Gastro Hep Adv] 2026 Mar 03; Vol. 5 (5), pp. 100912. Date of Electronic Publication: 2026 Mar 03 (Print Publication: 2026). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Elsevier Inc on behalf of the AGA Institute Country of Publication: Netherlands NLM ID: 9918350485906676 Publication Model: eCollection Cited Medium: Internet ISSN: 2772-5723 (Electronic) Linking ISSN: 27725723 NLM ISO Abbreviation: Gastro Hep Adv Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
